CY1118623T1 - Ενωσεις τετραϋδροπυρρολοθειαζινων ως αναστολεις της bace - Google Patents
Ενωσεις τετραϋδροπυρρολοθειαζινων ως αναστολεις της baceInfo
- Publication number
- CY1118623T1 CY1118623T1 CY20171100191T CY171100191T CY1118623T1 CY 1118623 T1 CY1118623 T1 CY 1118623T1 CY 20171100191 T CY20171100191 T CY 20171100191T CY 171100191 T CY171100191 T CY 171100191T CY 1118623 T1 CY1118623 T1 CY 1118623T1
- Authority
- CY
- Cyprus
- Prior art keywords
- bace
- compounds
- tetrahydropyrolthiazine
- suspensions
- och3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει ενώσεις του Τύπου I χρήσιμες ως αναστολείς της BACE για την αντιμετώπιση π.χ. της νόσου Alzheimer: όπου Α επιλέγεται από την ομάδα που αποτελείται από, από, R1 είναι Η ή F, R2 είναι Η, -OCH3, C1-C3 αλκύλιο, R3 είναι Η, -CH3 ή -OCH3 και R4 είναι Η ή F, ή φαρμακευτικώς αποδεκτό άλας.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261718728P | 2012-10-26 | 2012-10-26 | |
PCT/US2013/065418 WO2014066132A1 (en) | 2012-10-26 | 2013-10-17 | Bace inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1118623T1 true CY1118623T1 (el) | 2017-07-12 |
Family
ID=49515508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171100191T CY1118623T1 (el) | 2012-10-26 | 2017-02-10 | Ενωσεις τετραϋδροπυρρολοθειαζινων ως αναστολεις της bace |
Country Status (17)
Country | Link |
---|---|
US (1) | US9328124B2 (el) |
EP (1) | EP2912041B1 (el) |
JP (1) | JP6243921B2 (el) |
CN (1) | CN104755484B (el) |
CA (1) | CA2886507C (el) |
CY (1) | CY1118623T1 (el) |
DK (1) | DK2912041T3 (el) |
ES (1) | ES2616835T3 (el) |
HR (1) | HRP20170025T1 (el) |
HU (1) | HUE031764T2 (el) |
LT (1) | LT2912041T (el) |
ME (1) | ME02576B (el) |
PL (1) | PL2912041T3 (el) |
PT (1) | PT2912041T (el) |
RS (1) | RS55561B1 (el) |
SI (1) | SI2912041T1 (el) |
WO (1) | WO2014066132A1 (el) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2961749B1 (en) | 2013-03-01 | 2019-10-09 | Amgen Inc. | Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
CN105164121A (zh) | 2013-03-08 | 2015-12-16 | 美国安进公司 | 作为β分泌酶抑制剂的全氟化环丙基稠合的1,3-噁嗪-2-胺化合物以及其使用方法 |
TWI684452B (zh) * | 2014-03-14 | 2020-02-11 | 美國禮來大藥廠 | 胺基噻嗪化合物 |
AU2015301028B2 (en) | 2014-08-08 | 2019-09-26 | Amgen Inc. | Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use |
WO2017024180A1 (en) | 2015-08-06 | 2017-02-09 | Amgen Inc. | Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use |
WO2018112084A1 (en) | 2016-12-15 | 2018-06-21 | Amgen Inc. | Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use |
ES2910791T3 (es) | 2016-12-15 | 2022-05-13 | Amgen Inc | Derivados de tiazina como inhibidores de beta-secretasa y métodos de uso |
WO2018112081A1 (en) | 2016-12-15 | 2018-06-21 | Amgen Inc. | Oxazine derivatives as beta-secretase inhibitors and methods of use |
EP3555085B1 (en) | 2016-12-15 | 2020-12-02 | Amgen Inc. | Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use |
JP7149271B2 (ja) | 2016-12-15 | 2022-10-06 | アムジエン・インコーポレーテツド | β-セクレターゼ阻害剤としての1,4-チアジンジオキシドおよび1,2,4-チアジアジンジオキシド誘導体ならびに使用方法 |
CN106632001A (zh) * | 2016-12-28 | 2017-05-10 | 山东诚汇双达药业有限公司 | 一种4‑(溴乙酰基)吡啶氢溴酸盐的制备方法 |
CN110452179A (zh) * | 2019-06-25 | 2019-11-15 | 南京普锐达医药科技有限公司 | 一种2-氯-4-甲氧基-5-氰基嘧啶的合成方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201004961A (en) * | 2005-06-14 | 2010-02-01 | Schering Corp | Aspartyl protease inhibitors |
US8653067B2 (en) | 2007-04-24 | 2014-02-18 | Shionogi & Co., Ltd. | Pharmaceutical composition for treating Alzheimer's disease |
MY160690A (en) * | 2008-01-18 | 2017-03-15 | Eisai R&D Man Co Ltd | Condensed aminodihydrothiazine derivative |
AR072952A1 (es) | 2008-04-22 | 2010-10-06 | Schering Corp | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso |
JP5490692B2 (ja) | 2008-06-13 | 2014-05-14 | 塩野義製薬株式会社 | βセクレターゼ阻害作用を有する含硫黄複素環誘導体 |
CN102171221B (zh) | 2008-09-30 | 2013-11-06 | 卫材R&D管理有限公司 | 新的稠合的氨基二氢噻嗪衍生物 |
AR077277A1 (es) * | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
GB0912778D0 (en) * | 2009-07-22 | 2009-08-26 | Eisai London Res Lab Ltd | Fused aminodihydro-oxazine derivatives |
US20120245155A1 (en) | 2009-12-11 | 2012-09-27 | Shionogi & Co., Ltd. | Fused heterocyclic compound having amino group |
GB201100181D0 (en) | 2011-01-06 | 2011-02-23 | Eisai Ltd | Fused aminodihydrothiazine derivatives |
WO2012162334A1 (en) | 2011-05-24 | 2012-11-29 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
JO3143B1 (ar) | 2012-04-03 | 2017-09-20 | Lilly Co Eli | مركبات تتراهيدرو بيرولو ثيازين |
GB201212871D0 (en) * | 2012-07-20 | 2012-09-05 | Eisai Ltd | Novel compounds |
TWI593692B (zh) | 2013-03-12 | 2017-08-01 | 美國禮來大藥廠 | 四氫吡咯并噻嗪化合物 |
-
2013
- 2013-10-17 US US14/427,648 patent/US9328124B2/en not_active Expired - Fee Related
- 2013-10-17 DK DK13785730.6T patent/DK2912041T3/en active
- 2013-10-17 CA CA2886507A patent/CA2886507C/en not_active Expired - Fee Related
- 2013-10-17 PL PL13785730T patent/PL2912041T3/pl unknown
- 2013-10-17 PT PT137857306T patent/PT2912041T/pt unknown
- 2013-10-17 EP EP13785730.6A patent/EP2912041B1/en active Active
- 2013-10-17 JP JP2015539666A patent/JP6243921B2/ja not_active Expired - Fee Related
- 2013-10-17 CN CN201380055699.5A patent/CN104755484B/zh not_active Expired - Fee Related
- 2013-10-17 LT LTEP13785730.6T patent/LT2912041T/lt unknown
- 2013-10-17 ES ES13785730.6T patent/ES2616835T3/es active Active
- 2013-10-17 HU HUE13785730A patent/HUE031764T2/en unknown
- 2013-10-17 WO PCT/US2013/065418 patent/WO2014066132A1/en active Application Filing
- 2013-10-17 SI SI201330463T patent/SI2912041T1/sl unknown
- 2013-10-17 RS RS20170016A patent/RS55561B1/sr unknown
-
2017
- 2017-01-10 HR HRP20170025TT patent/HRP20170025T1/hr unknown
- 2017-02-10 ME MEP-2017-4A patent/ME02576B/me unknown
- 2017-02-10 CY CY20171100191T patent/CY1118623T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
LT2912041T (lt) | 2017-03-10 |
WO2014066132A1 (en) | 2014-05-01 |
US9328124B2 (en) | 2016-05-03 |
ES2616835T3 (es) | 2017-06-14 |
CN104755484B (zh) | 2016-02-17 |
EP2912041B1 (en) | 2016-12-14 |
JP6243921B2 (ja) | 2017-12-06 |
RS55561B1 (sr) | 2017-05-31 |
PL2912041T3 (pl) | 2017-06-30 |
CN104755484A (zh) | 2015-07-01 |
HUE031764T2 (en) | 2017-07-28 |
SI2912041T1 (sl) | 2017-02-28 |
HRP20170025T1 (hr) | 2017-03-10 |
EP2912041A1 (en) | 2015-09-02 |
PT2912041T (pt) | 2017-02-13 |
CA2886507C (en) | 2016-09-20 |
US20150232483A1 (en) | 2015-08-20 |
CA2886507A1 (en) | 2014-05-01 |
DK2912041T3 (en) | 2017-02-27 |
ME02576B (me) | 2017-06-20 |
JP2015535247A (ja) | 2015-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118623T1 (el) | Ενωσεις τετραϋδροπυρρολοθειαζινων ως αναστολεις της bace | |
CY1117688T1 (el) | Ενωσεις τετραϋδροπυρρολοθειαζινης | |
CY1120269T1 (el) | Ετεροδικυκλικες ενωσεις ως αναστολεις βητα-λακταμασης | |
CY1121677T1 (el) | Ενωσεις διμεθυλοβενζοϊκου οξεος | |
CY1124537T1 (el) | Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα | |
PH12016501535A1 (en) | Uracil derivatives as axl and c-met kinase inhibitors | |
PH12015502443A1 (en) | 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
PH12014502788A1 (en) | ARYL SULTAM DERIVATIVES AS RORc MODULATORS | |
PH12018500061A1 (en) | Oxysterols and methods of use thereof | |
CR20150085A (es) | Nuevas 6-aminoacido-heteroarildihidropirmidindas para el tratamiento y profilaxis de la infección del virus de la hepatitis b | |
MX2016006936A (es) | Benzamidas sustituidas y metodos para usarlas. | |
PH12014502396B1 (en) | Nitrogenated heterocyclic compound | |
EA201592082A1 (ru) | 3,4-дигидроизохинолин-2(1h)-ильные соединения | |
EA201101060A1 (ru) | Новые гербициды | |
EA201101148A1 (ru) | Новые гербициды | |
MX2015007097A (es) | Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer. | |
CY1119425T1 (el) | Ενωσεις φαινοξυαιθυλο πιπεριδινης | |
EA201101146A1 (ru) | Новые гербициды | |
EA201491276A1 (ru) | Новые производные бензилсульфонамида, подходящие для применения в качестве ингибиторов mogat-2 | |
CY1118371T1 (el) | Αναστολεις του iap | |
MX2015017156A (es) | Inhibidores de bace. | |
PH12014501712A1 (en) | Novel morpholinyl derivatives useful as mogat-2-inhibitors | |
EP2602254A4 (en) | HETEROCYCLIC COMPOUND | |
ME00582A (en) | Tricyclic compound and pharmaceutical use thereof | |
UY35685A (es) | Compuestos de dióxido de amino tiazina bicíclicos puenteados como inhibidores de beta-secretasa y sus métodos de uso |